Is methylene blue safe to use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety Profile of Methylene Blue

Methylene blue is generally safe when used appropriately, but has significant contraindications including absolute contraindication in patients taking SSRIs due to risk of life-threatening serotonin syndrome, and in patients with G6PD deficiency where it can cause severe hemolysis. 1

Appropriate Uses and Administration

Methylene blue is primarily used for:

  • Treatment of methemoglobinemia at a dose of 1-2 mg/kg IV over 3-5 minutes 1, 2
  • Diagnostic procedures during endoscopy 3
  • Management of vasoplegic syndrome 4
  • Treatment of ifosfamide-induced encephalopathy 5
  • Cyanide intoxication 6

When used for endoscopic procedures, methylene blue (0.5%-1.0%) is taken up by actively absorbing intestinal epithelial cells and has been applied to enhance detection of metaplastic epithelium such as Barrett's esophagus 3.

Major Contraindications

  1. Patients taking SSRIs:

    • Absolute contraindication due to high risk of potentially life-threatening serotonin syndrome
    • Methylene blue acts as a monoamine oxidase inhibitor (MAOI) even at doses as low as 0.75 mg/kg 7
    • Can lead to prolonged coma lasting 1-5 days and potentially fatal outcomes 1
  2. G6PD Deficiency:

    • Contraindicated due to risk of severe hemolysis 1, 2
    • Family history should be checked in emergency situations when testing is not possible 1

Special Populations Requiring Caution

  • Renal failure patients: Requires cautious use 1
  • Anesthetized patients: May inhibit guanylate cyclase, decreasing nitric oxide-mediated vasodilation leading to systemic and pulmonary hypertension 1
  • Premature infants: At risk of hemolysis and methemoglobinemia even with doses of 2-4 mg/kg 1
  • Patients exposed to aniline dyes and dapsone: Present special risks in treatment of methemoglobinemia 2

Side Effects and Toxicity

Methylene blue's toxic effects are dose-dependent and may include:

  • Hemolysis (especially at higher doses)
  • Methemoglobinemia (paradoxically)
  • Nausea and vomiting
  • Chest pain
  • Dyspnea
  • Hypertension
  • Skin irritation and inflammatory response 6

When used for endoscopic procedures, methylene blue:

  • May result in green hue to urine and stool for up to 24 hours
  • Has been speculated to potentially induce oxidative damage to DNA when photosensitized by white light 3
  • No significant side effects have been reported for endoscopic use 3

Proper Administration Guidelines

  • Maximum total dose should not exceed 7 mg/kg to avoid toxicity 1
  • Should be administered through a dedicated line to prevent medication incompatibilities 1
  • Patients should be monitored for rebound phenomenon 1
  • Adequate intravenous hydration, oxygen supplementation, and glucose availability should be ensured 1
  • For endoscopic procedures, optimal staining requires removal of surface mucus with a mucolytic agent such as 10% acetylcysteine solution 3

Key Monitoring Considerations

  • Monitor for signs of serotonin syndrome: neuromuscular hyperactivity, autonomic effects, and neurological effects 1, 7
  • Watch for symptoms of methemoglobinemia: cyanosis, shortness of breath, and fatigue 1
  • Ensure adequate glucose availability as it can hinder the effectiveness of methylene blue treatment 1

Common Pitfalls to Avoid

  1. Failing to screen for SSRI use before administration
  2. Not checking for G6PD deficiency status
  3. Exceeding the maximum recommended dose of 7 mg/kg
  4. Inadequate glucose availability during treatment
  5. Not monitoring for rebound phenomenon after administration

Methylene blue remains a valuable medication when used appropriately with proper screening for contraindications and careful monitoring for adverse effects.

References

Guideline

Methylene Blue Usage Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Methylene blue.

American journal of therapeutics, 2003

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Methylene blue for distributive shock: a potential new use of an old antidote.

Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.